Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-008064

Options or other derivatives

  • Chief Executive Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lynch Casey Chief Executive Officer 2020-02-06 Grant or award · Stock Option (Right to Buy) +175,000 175,000 D
Loading xslF345X03/doc4.xml…